Tetsuo Noguchi

A Phase II Study of Cisplatin Plus Gemcitabine followed by Maintenance Gemcitabine for Advanced Squamous Non-Small-Cell Lung Cancer: Kyoto Thoracic Oncology Research Group 1302

Y. Nakano, T. Hirai, Y. Hasegawa, 2019, Oncology.

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios alone or combined with prostate-specific antigen for the diagnosis of prostate cancer and clinically significant prostate cancer

Y. Ogawa, T. Fukagai, T. Shichijo, 2022, Asian journal of urology.